{"Abbreviation":"Adrenaline","Aliases":["DL-Adrenaline","Racepinephrine","(+-)-Adrenaline","Epinephrine dl-","Epinephrine, dl-","Racemic Epinephrine","Epinephrine dl-form","Racemic adrenaline","Adrenaline, racemic","Epinephrine, Racemic"],"Biological Half-Life":"To refer to the pharmacokinetic data of L-epinephrine, refer to the drug entry for [DB00668].","CAS":"329-65-7","ChEBI":"CHEBI:33568","ChEMBL":"CHEMBL1740","ChemicalClasses":["phenylethanolamine","catecholamine"],"Chirality":"racemic","Classes":["Neurotransmitters"],"Dosing Info":[{"Method":"Sublingual","Tiers":{"Common":{"Lower":0.3,"Upper":0.3},"Heavy":{"Lower":0.3,"Upper":0.3},"Light":{"Lower":0.3,"Upper":0.3},"Strong":{"Lower":0.3,"Upper":0.3},"Threshold":{"Lower":0.3,"Upper":0.3}},"Unit":"μg"}],"Drug Classes":"Breast Feeding; Lactation; Adrenergic Agonists; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Antiglaucoma Agents; Bronchodilator Agents; Catecholamines; Mydriatics; Sympathomimetics; Vasoconstrictor Agents","Drug Indication":"Indicated for temporary relief of mild symptoms of intermittent asthma.","DrugClasses":[],"DurationOfAction":"","EINECS":"206-347-6","EliminationHalfLife":"","Esters":["acetate"],"European Community (EC) Number":"206-347-6","FullSalts":["Epinephrine hydrochloride","Epinephrine sulfate","Epinephrine acetate","Epinephrine bitartrate"],"HMDB ID":"HMDB0062515","HeavyAtomCount":13,"Human Drugs":"Breast Feeding; Lactation; Adrenergic Agonists; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Antiglaucoma Agents; Bronchodilator Agents; Catecholamines; Mydriatics; Sympathomimetics; Vasoconstrictor Agents","IUPACName":"4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol","InChI":"InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3","InChIKey":"UCTWMZQNUQWSLP-UHFFFAOYSA-N","MeSH Pharmacological Classification":"Drugs that selectively bind to and activate alpha adrenergic receptors. (See all compounds classified as Adrenergic alpha-Agonists.)","MolecularFormula":"C\u003csub\u003e9\u003c/sub\u003eH\u003csub\u003e13\u003c/sub\u003eNO\u003csub\u003e3\u003c/sub\u003e","MolecularWeight":"183.20 g/mol","Opticalactivity":"( + / - )","Pharmacodynamics":"Epinephrine acts on α- and β-adrenergic receptors. When given subcutaneously or intramuscularly, epinephrine has a rapid onset and short duration of action. Epinephrine induces bronchial smooth muscle relaxation to relieve respiratory distress in asthma. In a clinical trial of paediatric patients with bronchiolitis, administration of aerosolized racemic epinephrine via inhalation resulted in improved clinical symptoms such as wheezing and retractions. The clinical efficacy of racemic epinephrine was comparable to that of salbutamol or albuterol, which are commonly used bronchodilators.","PrevSalts":["hydrochloride"],"PubChemId":838,"Record Description":["Adrenaline is a racemate comprising equimolar amounts of (R)-adrenaline and (S)-adrenaline. It has a role as a human metabolite. It contains a (R)-adrenaline and a (S)-adrenaline.","Racepinephrine is a racemic mixture consisting of d-[DB00668] and l-[DB00668] enantiomers. Epinephrine is a non-selective α- and β-adrenergic receptor agonist. It is a bronchodilator used in the temporary relief of mild symptoms of intermittent asthma including wheezing, tightness of chest and shortness of breath. It is an active ingredient in oral inhalation over-the-counter products as racepinephrine hydrochloride.","DL-Adrenaline has been reported in Homo sapiens with data available.","RACEPINEPHRINE is a small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication.","A racemic mixture of d-epinephrine and l-epinephrine.","See also: Racepinephrine Hydrochloride (has salt form); Epinephrine (annotation moved to) ... View More ...","Adrenaline is a racemate comprising equimolar amounts of (R)-adrenaline and (S)-adrenaline. It has a role as a human metabolite. It contains a (R)-adrenaline and a (S)-adrenaline."],"References":[{"Name":"Wikipedia","Urls":[{"Link":"https://en.wikipedia.org/wiki/Racepinefrine","Name":"Epinephrine","Sub":false}]},{"Name":"Wikidata","Urls":[{"Link":"https://www.wikidata.org/wiki/Q7279006","Name":"Epinephrine","Sub":false},{"Link":"https://www.wikidata.org/wiki/Q27074317","Name":"(+)-Epinephrine","Sub":true},{"Link":"https://www.wikidata.org/wiki/Q132621","Name":"(-)-Epinephrine","Sub":true}]},{"Name":"DrugBank","Urls":[{"Link":"https://go.drugbank.com/drugs/DB11124","Name":"Epinephrine","Sub":false},{"Link":"https://go.drugbank.com/drugs/DB00668","Name":"(-)-Epinephrine","Sub":true}]},{"Name":"PubChem","Urls":[{"Link":"https://pubchem.ncbi.nlm.nih.gov/compound/838","Name":"Epinephrine","Sub":false},{"Link":"https://pubchem.ncbi.nlm.nih.gov/compound/247704","Name":"(+)-Epinephrine","Sub":true},{"Link":"https://pubchem.ncbi.nlm.nih.gov/compound/5816","Name":"(-)-Epinephrine","Sub":true}]},{"Name":"ChEMBL","Urls":[{"Link":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1740","Name":"Epinephrine","Sub":false},{"Link":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL42280","Name":"(+)-Epinephrine","Sub":true},{"Link":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL679","Name":"(-)-Epinephrine","Sub":true}]},{"Name":"ChEBI","Urls":[{"Link":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:33568","Name":"Epinephrine","Sub":false},{"Link":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:40751","Name":"(+)-Epinephrine","Sub":true},{"Link":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:28918","Name":"(-)-Epinephrine","Sub":true}]},{"Name":"Common Chemistry","Urls":[{"Link":"https://commonchemistry.cas.org/detail?cas_rn=329-65-7","Name":"Epinephrine","Sub":false},{"Link":"https://commonchemistry.cas.org/detail?cas_rn=150-05-0","Name":"(+)-Epinephrine","Sub":true},{"Link":"https://commonchemistry.cas.org/detail?cas_rn=51-43-4","Name":"(-)-Epinephrine","Sub":true}]},{"Name":"HMDB","Urls":[{"Link":"https://hmdb.ca/metabolites/HMDB0062515","Name":"Epinephrine","Sub":false},{"Link":"https://hmdb.ca/metabolites/HMDB0000068","Name":"(-)-Epinephrine","Sub":true}]},{"Name":"KEGG","Urls":[{"Link":"https://www.kegg.jp/entry/D05688","Name":"Epinephrine","Sub":false},{"Link":"https://www.kegg.jp/entry/C00788","Name":"(-)-Epinephrine","Sub":true}]},{"Name":"UNII","Urls":[{"Link":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/GR0L9S3J0F","Name":"Epinephrine","Sub":false},{"Link":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/NA71GR3TNV","Name":"(+)-Epinephrine","Sub":true},{"Link":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/YKH834O4BH","Name":"(-)-Epinephrine","Sub":true}]},{"Name":"EPA DSSTox","Urls":[{"Link":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID80858965","Name":"Epinephrine","Sub":false},{"Link":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID301047668","Name":"(+)-Epinephrine","Sub":true},{"Link":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022986","Name":"(-)-Epinephrine","Sub":true}]}],"SMILES":"CNCC(C1=CC(=C(C=C1)O)O)O","Salts":["hydrochloride","sulfate","acetate","bitartrate"],"SaltsAcidCount":[1,0,0,0],"SaltsAmineCount":[1,0,1,1],"SaltsUNII":["336096P2WE","CM4IBP5LLV","M1NJX34RVJ","30Q7KI53AK"],"Scheduling":[],"Solubility":"Soluble","StereoisomerRacemic":"(RS)-Epinephrine","Stereoisomers":["(+)-Epinephrine","(-)-Epinephrine"],"StereoisomersUNII":["NA71GR3TNV","YKH834O4BH"],"StoreUNII":["GR0L9S3J0F"],"StructureBase64":"<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" height="51.882mm" version="1.2" viewBox="0 0 100.557 51.882" width="100.557mm">
      
    <desc>Generated by the Chemistry Development Kit (http://github.com/cdk)</desc>
      
    <g fill="#FF0D0D" stroke="#000000" stroke-linecap="round" stroke-linejoin="round" stroke-width=".7">
            
        <rect fill="#FFFFFF" height="52.0" stroke="none" width="101.0" x=".0" y=".0"/>
            
        <g class="mol" id="mol1">
                  
            <line class="bond" id="mol1bnd1" x1="99.519" x2="89.474" y1="25.941" y2="20.142"/>
                  
            <line class="bond" id="mol1bnd2" x1="83.168" x2="73.123" y1="20.142" y2="25.941"/>
                  
            <line class="bond" id="mol1bnd3" x1="73.123" x2="59.924" y1="25.941" y2="18.321"/>
                  
            <line class="bond" id="mol1bnd4" x1="59.924" x2="46.726" y1="18.321" y2="25.941"/>
                  
            <g class="bond" id="mol1bnd5">
                        
                <line x1="46.726" x2="33.523" y1="25.941" y2="18.313"/>
                        
                <line x1="44.288" x2="33.523" y1="27.349" y2="21.129"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd6" x1="33.523" x2="20.325" y1="18.313" y2="25.933"/>
                  
            <g class="bond" id="mol1bnd7">
                        
                <line x1="20.325" x2="20.33" y1="25.933" y2="41.181"/>
                        
                <line x1="22.764" x2="22.768" y1="27.34" y2="39.774"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd8" x1="20.33" x2="33.533" y1="41.181" y2="48.81"/>
                  
            <g class="bond" id="mol1bnd9">
                        
                <line x1="33.533" x2="46.731" y1="48.81" y2="41.19"/>
                        
                <line x1="33.533" x2="44.292" y1="45.994" y2="39.782"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd10" x1="46.726" x2="46.731" y1="25.941" y2="41.19"/>
                  
            <line class="bond" id="mol1bnd11" x1="20.33" x2="10.41" y1="41.181" y2="46.908"/>
                  
            <line class="bond" id="mol1bnd12" x1="20.325" x2="10.401" y1="25.933" y2="20.205"/>
                  
            <line class="bond" id="mol1bnd13" x1="59.924" x2="59.924" y1="18.321" y2="7.002"/>
                  
            <g class="atom" id="mol1atm2">
                        
                <path d="M88.262 20.771h-.721l-2.619 -4.066h-.03q.012 .238 .03 .595q.024 .357 .024 .732v2.739h-.566v-4.9h.715l2.607 4.055h.03q-.006 -.108 -.018 -.328q-.012 -.22 -.024 -.476q-.006 -.262 -.006 -.482v-2.769h.578v4.9z" fill="#3050F8" stroke="none"/>
                        
                <path d="M88.125 15.31h-.619v-2.286h-2.513v2.286h-.613v-4.9h.613v2.072h2.513v-2.072h.619v4.9z" fill="#3050F8" stroke="none"/>
                      
            </g>
                  
            <g class="atom" id="mol1atm11">
                        
                <path d="M9.391 48.798q-.0 .756 -.256 1.328q-.256 .565 -.756 .881q-.5 .315 -1.245 .315q-.756 .0 -1.262 -.315q-.506 -.316 -.756 -.887q-.244 -.572 -.244 -1.334q.0 -.75 .244 -1.309q.25 -.566 .756 -.881q.506 -.316 1.274 -.316q.733 .0 1.233 .316q.5 .309 .756 .875q.256 .565 .256 1.327zM5.527 48.798q.0 .923 .387 1.459q.393 .53 1.22 .53q.84 -.0 1.221 -.53q.387 -.536 .387 -1.459q-.0 -.929 -.387 -1.452q-.381 -.524 -1.209 -.524q-.833 -.0 -1.226 .524q-.393 .523 -.393 1.452z" stroke="none"/>
                        
                <path d="M4.311 51.251h-.62v-2.286h-2.512v2.286h-.613v-4.9h.613v2.072h2.512v-2.072h.62v4.9z" stroke="none"/>
                      
            </g>
                  
            <g class="atom" id="mol1atm12">
                        
                <path d="M9.385 18.312q-.0 .756 -.256 1.327q-.256 .566 -.756 .881q-.5 .316 -1.245 .316q-.756 -.0 -1.262 -.316q-.506 -.315 -.756 -.887q-.244 -.571 -.244 -1.333q.0 -.75 .244 -1.31q.25 -.565 .756 -.881q.506 -.315 1.274 -.315q.733 -.0 1.233 .315q.5 .31 .756 .875q.256 .566 .256 1.328zM5.521 18.312q.0 .923 .387 1.458q.393 .53 1.22 .53q.84 .0 1.221 -.53q.387 -.535 .387 -1.458q-.0 -.929 -.387 -1.453q-.381 -.524 -1.209 -.524q-.833 .0 -1.226 .524q-.393 .524 -.393 1.453z" stroke="none"/>
                        
                <path d="M4.305 20.765h-.62v-2.286h-2.512v2.286h-.613v-4.9h.613v2.072h2.512v-2.072h.62v4.9z" stroke="none"/>
                      
            </g>
                  
            <g class="atom" id="mol1atm13">
                        
                <path d="M62.184 3.078q-.0 .756 -.256 1.328q-.256 .565 -.756 .881q-.5 .315 -1.245 .315q-.756 .0 -1.262 -.315q-.506 -.316 -.756 -.887q-.244 -.572 -.244 -1.334q.0 -.75 .244 -1.309q.25 -.566 .756 -.881q.506 -.316 1.274 -.316q.733 .0 1.233 .316q.5 .309 .756 .875q.256 .565 .256 1.327zM58.32 3.078q.0 .923 .387 1.459q.393 .53 1.22 .53q.84 -.0 1.221 -.53q.387 -.536 .387 -1.459q-.0 -.929 -.387 -1.452q-.381 -.524 -1.209 -.524q-.833 -.0 -1.226 .524q-.393 .523 -.393 1.452z" stroke="none"/>
                        
                <path d="M66.49 5.531h-.619v-2.286h-2.513v2.286h-.613v-4.9h.613v2.072h2.513v-2.072h.619v4.9z" stroke="none"/>
                      
            </g>
                
            <line class="hi" id="mol1bnd1" stroke="#3050F8" x1="89.474" x2="94.4965" y1="20.142" y2="23.0415"/>
            <line class="hi" id="mol1bnd1" stroke="#3050F8" x1="89.474" x2="94.4965" y1="20.142" y2="23.0415"/>
            <line class="hi" id="mol1bnd2" stroke="#3050F8" x1="83.168" x2="78.1455" y1="20.142" y2="23.0415"/>
            <line class="hi" id="mol1bnd2" stroke="#3050F8" x1="83.168" x2="78.1455" y1="20.142" y2="23.0415"/>
            <line class="hi" id="mol1bnd11" stroke="#FF0D0D" x1="10.41" x2="15.37" y1="46.908" y2="44.0445"/>
            <line class="hi" id="mol1bnd11" stroke="#FF0D0D" x1="10.41" x2="15.37" y1="46.908" y2="44.0445"/>
            <line class="hi" id="mol1bnd12" stroke="#FF0D0D" x1="10.401" x2="15.363" y1="20.205" y2="23.069"/>
            <line class="hi" id="mol1bnd12" stroke="#FF0D0D" x1="10.401" x2="15.363" y1="20.205" y2="23.069"/>
            <line class="hi" id="mol1bnd13" stroke="#FF0D0D" x1="59.924" x2="59.924" y1="7.001999999999999" y2="12.6615"/>
            <line class="hi" id="mol1bnd13" stroke="#FF0D0D" x1="59.924" x2="59.924" y1="7.001999999999999" y2="12.6615"/>
        </g>
          
    </g>
    
</svg>
","Title":"Epinephrine","UNII":"GR0L9S3J0F","Wikidata":"Q7279006","Wikipedia":"Racepinefrine","XLogP":-1.4}